openPR Logo
Press release

Granulocyte-colony stimulating factor (G-CSF) category shall dominate the Oncology Biosimilars Market, capturing more than 3/5th of the total market share

02-03-2021 02:45 PM CET | Health & Medicine

Press release from: Fact.MR

Oncology Biosimilars Market

Oncology Biosimilars Market

The demand for oncology biosimilar drugs has augmented in recent years. This is attributed to the rising prevalence of various types of cancers across the world. In addition, existing anti-cancer drugs in the pipeline are quite expensive, thus rendering them unaffordable to people in lower and middle income countries. As a consequence, the market for biosimilars has burgeoned.

However, the current COVID-19 pandemic is poised to stall growth trajectory of the market, owing to supply chain disruptions from leading biosimilar manufacturing hubs and shifting priorities of healthcare providers. These shifting priorities are delaying clinical trials for biosimilars, thus delaying their adoption. However, long-term prospects are highly optimistic, with the industry registering an aggrandizing CAGR of 29.4% by 2025-end.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4800

Key Takeaways of Oncology Biosimilars Market Study:

• By drug class, the granulocyte-colony stimulating factor (G-CSF) category shall dominate the oncology biosimilars market, capturing more than 3/5th of the total market share. Rising adoption of chemotherapy is the key growth driver of the segment. However, monoclonal antibodies are set to grow the fastest, expanding 4.0x, attributed to modification of manufacturing facilities to develop complex and effective drugs.
• By disease indication, the blood cancer and neutropenia segments are set to account for the majority of the market share, accounting for 22.3% and 54.7% respectively. Rising FDA approvals for biosimilar products manufactured by leading market players are attributed as key drivers behind the expansion. Examples of such drugs are filgrastim-sndz and filgrastim-aafi.
• By end-user, hospital pharmacies shall expand the fastest, at a whopping CAGR of 29.5%. The growing trend of physicians prescribing biosimilars instead of generic drugs is anticipated to heighten market prospects for the segment. More than half of the global oncology biosimilars market is set to be captured by the hospitals segment.
• Asia-Pacific dominates the oncology biosimilars market. Financial leverage by virtue of collaborations between leading giants is a key growth driver. The region is anticipated to capture over one-third market share, expanding at a CAGR of 30.7% across the forecast period. Trailing behind is North America, with a projected market share of 28.4% and a CAGR of 32.0%. New pipeline drugs are attributed as key growth levers.

For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4800

“The global oncology biosimilar drugs are finding increased application to treat cancer patients, burgeoned by the rapid phasing out of generic and blockbuster drugs. Key players are concentrating on expanding their product pipeline to provide room for manufacturing these drugs,” concludes a Fact.MR analyst.

Global Oncology Biosimilars Market: Competition Structure:

The global oncology biosimilars market consists of the following market players: Celltrion, Inc., Dr. Reddy’s Laboratories Ltd., Biocon, Teva Pharmaceutical Industries Ltd., and Sandoz International GmBh. This makes it a highly consolidated market. Collectively, these market players account for more than 70% of the market share. In order to increase their market footprints, these companies rely heavily on strengthening their product distribution networks through active collaborations.

Biocon, for instance, announced an exclusive global collaboration with Sandoz on next-generation biosimilars in 2018. Likewise, Dr. Reddy’s collaborated with TR Pharm to launch three biosimilars in Turkey in 2016. Other prominent market players in the global oncology biosimilars market include Pfizer, Inc., Celltrion, Inc., Sandoz International GmBh, STADA Arzneimittel AG and Apotex, Inc. to name a few.

Get Full Access of the Report @ https://www.factmr.com/checkout/4800/S

Looking for more information?

The research study on the global oncology biosimilars market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the oncology biosimilars market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during the time period. Market statistics have been presented on the basis of drug class (G-CSF, Monoclonal Antibody and Hematopoietic Agents), disease indication (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Neutropenia, Blood Cancer and Others) and distribution channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) across four major regions.

Fact. MR’s Domain Knowledge in Healthcare

Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions.

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Website : https://www.factmr.com

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Granulocyte-colony stimulating factor (G-CSF) category shall dominate the Oncology Biosimilars Market, capturing more than 3/5th of the total market share here

News-ID: 2235703 • Views:

More Releases from Fact.MR

UK Electric Vehicle Insulation Industry Forecast 2025-2035: Trends and Growth Insights
UK Electric Vehicle Insulation Industry Forecast 2025-2035: Trends and Growth In …
The UK's demand for electric vehicle insulation is expected to increase at a compound annual growth rate (CAGR) of 13.7% between 2025 and 2035, from USD 66.5 million in 2025 to over USD 239.3 million by that time. As electrification accelerates in the United Kingdom, demand for high-performance insulation materials for electric vehicles (EVs) - covering thermal, electrical, and acoustic protection - is rising rapidly. Insulation plays a critical role in
European Walnut Ingredients Market Forecast 2025-2035: Trends and Growth Insights
12-10-2025 | Food & Beverage
Fact.MR
European Walnut Ingredients Market Forecast 2025-2035: Trends and Growth Insight …
The walnut ingredients market is experiencing significant growth as consumer interest in nutrient-dense, plant-based, and functional food ingredients continues to rise. Walnuts are widely recognized for their rich nutritional composition, containing essential fatty acids, antioxidants, proteins, and vitamins that support heart health, cognitive function, and overall wellness. This rising health awareness, along with increased applications in processed foods, bakery, snacks, and cosmetics, is driving consistent demand for walnut-derived ingredients across
European Trail Mix Market Outlook 2025-2035: Innovation, Growth, and Demand Trends
12-10-2025 | Food & Beverage
Fact.MR
European Trail Mix Market Outlook 2025-2035: Innovation, Growth, and Demand Tren …
The global trail mix market is expected to experience robust growth over the next decade as consumer demand for convenient, healthy, and nutrient-rich snacks continues to rise. Trail mix - a combination of nuts, seeds, dried fruits, and occasionally chocolate or other ingredients - has evolved from a niche outdoor snack to a mainstream, on-the-go option favored by fitness enthusiasts, busy professionals, and health-conscious individuals. Rising awareness of nutritional benefits,
European Specialty Fertilizers Market Forecast 2025-2035: Trends and Growth Insights
European Specialty Fertilizers Market Forecast 2025-2035: Trends and Growth Insi …
The global specialty fertilizers market is poised for robust growth over the next decade as demand increases for high-efficiency, targeted nutrient delivery solutions tailored to modern agriculture, horticulture, and specialty crop production. Specialty fertilizers - including controlled-release, water-soluble, micronutrient-enriched and customized nutrient blends - are gaining prominence as farmers and agribusinesses increasingly prioritize yield optimization, resource efficiency, soil health, and environmental sustainability. Rapid urbanization, population growth, shrinking arable land per capita,

All 5 Releases


More Releases for Oncology

Precision Oncology Market Top Companies Study - Laboratory Corporation of Americ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies)- Market Outlook And Industry Analysis 2031" The global Precision Oncology market is estimated to reach over USD
Veterinary Oncology Market Report 2024 - Veterinary Oncology Market Size, Share …
"The Business Research Company recently released a comprehensive report on the Global Veterinary Oncology Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The veterinary oncology market size
Hepatocellular Carcinoma Pipeline 2024 | Can-Fite BioPharma, Sinocelltech, AVEO …
DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Hepatocellular Carcinoma Pipeline
Oncology Clinical Trials Market: Collaboration and Innovation in Oncology Resear …
Allied Market Research analysts have recently conducted a comprehensive research study titled "Oncology Clinical Trials Market: Global Outlook and Forecast 2023-2030." The report provides detailed information and analysis on key players in the market, including PAREXEL International, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, Novartis, Merck, Bristol Myers Squibb company, and F. Hoffmann-La Roche. The study offers an in-depth analysis that encompasses clear market definitions, classifications, manufacturing processes, cost
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study
Oncology Market Size to Hit $447.3 Billion by 2028 | Oncology Industry Forecast …
Market Overview: According to our experience research team, Oncology Market was valued at USD 283.5 Billion in 2021, and the global Oncology industry is projected to reach a value of USD 447.3 Billion by 2028, at a CAGR of 7.9% during the forecast period 2022-2028 Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy & Power, Agriculture,